Answers are grounded in this paper and cite their sources.
Conclusion We have shown that all of seven unrelated patients with defective palmitoyl‐CoA dehydrogenation have mutations in VLCAD, indicating that they suffer from VLCAD deficiency. Our study illustrations that there is a large mutational heterogeneity in VLCAD deficiency. It is not at present possible to judge whether or to what extent this large mutational heterogeneity may explain the varying clinical picture observed in this disease.
No takes yet. Share an insight, caveat, or question.
Andresen et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: